Designed CXCR4 mimic acts as a soluble chemokine receptor that blocks atherogenic inflammation by agonist-specific targeting

Christos Kontos, Omar El Bounkari, Christine Krammer, Dzmitry Sinitski, Kathleen Hille, Chunfang Zan, Guangyao Yan, Sijia Wang, Ying Gao, Markus Brandhofer, Remco T. A. Megens, Adrian Hoffmann, Jessica Pauli, Yaw Asare, Simona Gerra, Priscila Bourilhon, Lin Leng, Hans-Henning Eckstein, Wolfgang E. Kempf, Jaroslav PelisekOzgun Gokce, Lars Maegdefessel, Richard Bucala, Martin Dichgans, Christian Weber, Aphrodite Kapurniotu, Juergen Bernhagen

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Article number5981
Number of pages18
JournalNature Communications
Volume11
Issue number1
DOIs
Publication statusPublished - 25 Dec 2020

Keywords

  • MIGRATION-INHIBITORY FACTOR
  • CELL-DERIVED FACTOR-1-ALPHA
  • FACTOR MIF
  • CYTOKINE
  • ATHEROSCLEROSIS
  • EXPRESSION
  • BINDING
  • CXCL12
  • MOUSE
  • LIGAND

Cite this